Previous Close | 0.0500 |
Open | 0.0500 |
Bid | 0.0450 x N/A |
Ask | 0.0500 x N/A |
Day's Range | 0.0450 - 0.0500 |
52 Week Range | 0.0300 - 0.1950 |
Volume | |
Avg. Volume | 95,387 |
Market Cap | 4.217M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.1440 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Pathway Health Corp. (TSXV: PHC) ("Pathway" or the "Company") is pleased to announce that, further to its press release of February 3, 2023, it has elected to draw down $500,000 (the "Draw Down") under the $1.25 million secured convertible promissory grid note (the "Note") with HEAL Global Holdings Corp. (the "Lender"), an entity controlled by the Company's largest indirect beneficial shareholder Avonlea-Drewry Holdings Inc., and which is a party to the Company's previously announced letter of i
Pathway Health Corp. (TSXV: PHC) ("Pathway" or the "Company") is pleased to announce a proposed $1.25 million private placement of a secured convertible promissory note with HEAL Global Holdings Corp. (the "Lender"), an entity controlled by the Company's largest indirect beneficial shareholder Avonlea-Drewry Holdings Inc. ("ADH"), and which is a party to the Company's previously announced letter of intent ("LOI") in respect of a proposed business acquisition, recapitalization and debt restructur